Form D · Other Health Care

NantCell, Inc.

Culver City, CA · CIK 0001642116

Offering snapshot reported Mar 14, 2019 · SEC filing

Reported sold
$30M
Offering amount: $30M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 11, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 14, 2019Initial$30,000,000No comparison1SEC filing
Dec 27, 2018Initial$30,000,000No comparison1SEC filing
Apr 14, 2017Initial$5,000,000No comparison24SEC filing
Oct 14, 2016Initial$4,250,000No comparison1SEC filing
Jan 22, 2016Initial$57,340,243No comparison125SEC filing
Sep 11, 2015Initial$100,000,000No comparison1SEC filing
Jun 3, 2015Initial$75,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-334811

Source: Form D, filed Mar 14, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Patrick Shoon Shiong Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
9920 Jefferson Blvd
Culver City, CA, 90232